President Donald Trump’s physician, Dr. Sean P. Barbabella, announced that after conducting a battery of tests, he found that ...

Cambridge: Moderna, Inc. has announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the ...

Companies to Leverage Innovative AI Platform to Further Define Major Shovel-Ready Metals Resource, Poised to Become One of World’s Largest Deposits DALLAS, TX / ACCESS Newswire / October 22, 2025 / ...

Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven ...

Moderna stock toppled Thursday after the biotech company's experimental CMV vaccine failed in a Phase 3 study of 7,500 women.

Moderna said its cytomegalovirus (CMV) vaccine, mRNA-1647, failed to prevent infection in women of childbearing age in a ...

The vaccine, known as mRNA-1647, showed disappointing efficacy against primary CMV infection in healthy women, ranging from ...

(NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

PROVO, Utah – As the high-profile capital murder case against Tyler Robinson, the alleged assassin in the murder of Turning Point USA founder Charlie Kirk, continues to unfold, a legal expert is ...

California made history Wednesday by enacting the first law in the United States to define and ultimately ban unhealthy ultraprocessed foods, or UPFs, from what’s projected to be over 1 billion meals ...

The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s in vivo mRNA-encoded CAR T-cell program. In an interesting—if not somewhat ...